ALFA Finder
Fri, 13 Nov
Manorama Industries
Strong H1 performance driven by volume growth and value-added product mix despite freight headwinds.
Summary ready
Earnings calls
Manorama Industries concalls
Every Manorama Industries earnings call we streamed: the live audio and our summary of what management said.
Calls
Q2 FY27: key takeaways
Call page →Strong H1 performance driven by volume growth and value-added product mix despite freight headwinds.
Outlook
Targeting 85% utilization on expanded 47.5k MT capacity; new projects slated for FY28/FY29.
Earlier call summaries
All →
17:15 IST
NSE
Earnings Call
Manorama Industries Earnings Call Transcript: Key Takeaways
Manorama Industries delivered record Q1 FY27 revenue and EBITDA, reaching a 4,000 million INR milestone. Growth was primarily volume-led, supported by expanded fractionation capacity and strong export demand for specialty fats.
16:52 IST
BSE
Earnings Call
Manorama Industries Earnings Call: Key Takeaways
Manorama Industries reported strong FY26 results with a 76.1% revenue increase, driven by capacity expansion and a shift toward high-margin specialty fats and cocoa butter equivalents.
16:17 IST
BSE
Earnings Call
Manorama Industries Earnings Call: Key Takeaways
Manorama Industries delivered explosive FY26 growth, with standalone revenue surging 76% YoY to ₹1,358 crore, driven by a 30% capacity expansion in solvent fractionation and improved product mix towards high-value CBE products.
19:54 IST
BSE
Earnings Call
Manorama Industries Earnings Call: Key Takeaways
Manorama Industries delivered record FY26 performance with 76.1% revenue growth, driven by specialty fat demand and capacity expansion. Management outlined a ₹460Cr capex plan for further integration.
Manorama Industries Limited: key numbers
- Share price
- ₹1,984.10
- Market cap
- ₹12,524 Cr
- Revenue (annual)
- ₹1,367 Cr
- Net profit (annual)
- ₹224.9 Cr
- P/E (TTM)
- 45.7×Sector 29.1×
- Promoter holding
- 51.38%-2.94% QoQ
- FII holding
- 4.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.